SGLT2 Inhibitor, an Agent for Diabetes, Heart, Kidney ... and Stroke

被引：0
|
作者：
Yang, Taeil [1 ]
Lee, Jooyeon [1 ]
Oh, Jaewon [1 ]
机构：
[1] Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Cardiovasc Res Inst,Div Cardiol, 50-1,Yonsei Ro, Seoul 03722, South Korea
来源：
KOREAN CIRCULATION JOURNAL | 2024年 / 54卷 / 09期
关键词：
D O I：
10.4070/kcj.2024.0214
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：562 / 564
页数：3
相关论文
共 50 条
  • [41] SGLT2 inhibitor therapy in patients with type-2 diabetes mellitus: is acute kidney injury a concern?
    Baker, Megan Leila
    Perazella, Mark Anthony
    JOURNAL OF NEPHROLOGY, 2020, 33 (05) : 985 - 994
  • [42] The Efficacy and Safety of SGLT2 Inhibitor in Diabetic Kidney Transplant Recipients
    Lim, Jeong-Hoon
    Kwon, Soie
    Jeon, Yena
    Kim, Young Hoon
    Kwon, Hyunwook
    Kim, Yon Su
    Lee, Hajeong
    Kim, Yong-Lim
    Kim, Chan-Duck
    Park, Sun-Hee
    Lee, Jong Soo
    Yoo, Kyung Don
    Son, Hyung Eun
    Jeong, Jong Cheol
    Lee, Jeonghwan
    Lee, Jung Pyo
    Cho, Jang-Hee
    TRANSPLANTATION, 2022, 106 (09) : E404 - E412
  • [43] SGLT2 Inhibitor Use and Kidney Outcomes in Persons Receiving Cisplatin
    Idowu, Abiodun Benjamin
    Lo, Kevin Bryan
    Mathew, Roy O.
    Garimella, Pranav S.
    Rangaswami, Janani
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [44] SGLT2 Inhibitor Prescribing in Cardiovascular-Kidney-Metabolic Syndrome
    Beers, Brandon D.
    Chebrolu, Bhavya
    Stern, Gretchen M.
    Buckley, Leo F.
    Vaduganathan, Muthiah
    Bhatt, Deepak L.
    Bernier, Thomas D.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2024, 24 (06) : 841 - 844
  • [45] Considerations for SGLT2 inhibitor use in post-transplantation diabetes
    Manfred Hecking
    Trond Jenssen
    Nature Reviews Nephrology, 2019, 15 : 525 - 526
  • [46] Remogliflozin etabonate: a novel SGLT2 inhibitor for treatment of diabetes mellitus
    Mikhail, Nasser
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (10) : 1381 - 1387
  • [47] SGLT2 Inhibitor-Induced Ketoacidosis in a Patient Without Diabetes
    Hayes, Annabelle G.
    Raven, Lisa M.
    Viardot, Alexander
    Kotlyar, Eugene
    Greenfield, Jerry R.
    DIABETES CARE, 2024, 47 (01) : e4 - e5
  • [48] Can SGLT2 Inhibitor be Used for Diabetes Mellitus or Vascular Diseases?
    Nomiyama, Takashi
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2020, 27 (11) : 1139 - 1140
  • [49] SGLT2 Inhibitors: Effect on Myocardial Infarction and Stroke in Type 2 Diabetes
    Mukhopadhyay, Pradip
    Sanyal, Debmalya
    Chatterjee, Purushottam
    Pandit, Kaushik
    Ghosh, Sujoy
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (08): : 2134 - 2140
  • [50] Considerations for SGLT2 inhibitor use in post-transplantation diabetes
    Hecking, Manfred
    Jenssen, Trond
    NATURE REVIEWS NEPHROLOGY, 2019, 15 (09) : 525 - 526
12345